CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.39
2.21%
Market Trading Hours* (UTC) Open now
Closes on Friday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.04
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange France
Commission on trade 0%

*Information provided by Capital.com

Dbv Technologies SA ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.36
Open* 1.42
1-Year Change* -45.17%
Day's Range* 1.36 - 1.42
52 wk Range 1.38-4.30
Average Volume (10 days) 95.83K
Average Volume (3 months) 4.08M
Market Cap 164.04M
P/E Ratio -100.00K
Shares Outstanding 96.10M
Revenue 4.83M
EPS -0.99
Dividend (Yield %) N/A
Beta 0.88
Next Earnings Date Feb 29, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 22, 2024 1.36 0.04 3.03% 1.32 1.40 1.32
Feb 21, 2024 1.33 0.01 0.76% 1.32 1.35 1.29
Feb 20, 2024 1.30 -0.01 -0.76% 1.31 1.35 1.22
Feb 19, 2024 1.25 -0.38 -23.31% 1.63 1.64 1.05
Feb 16, 2024 1.64 0.02 1.23% 1.62 1.66 1.62
Feb 15, 2024 1.64 0.06 3.80% 1.58 1.66 1.57
Feb 14, 2024 1.58 0.02 1.28% 1.56 1.62 1.56
Feb 13, 2024 1.59 -0.03 -1.85% 1.62 1.65 1.57
Feb 12, 2024 1.64 0.09 5.81% 1.55 1.67 1.55
Feb 9, 2024 1.55 -0.05 -3.13% 1.60 1.63 1.54
Feb 8, 2024 1.60 -0.05 -3.03% 1.65 1.71 1.60
Feb 7, 2024 1.65 -0.03 -1.79% 1.68 1.71 1.65
Feb 6, 2024 1.69 0.02 1.20% 1.67 1.71 1.66
Feb 5, 2024 1.69 0.02 1.20% 1.67 1.69 1.65
Feb 2, 2024 1.66 -0.03 -1.78% 1.69 1.72 1.65
Feb 1, 2024 1.68 -0.01 -0.59% 1.69 1.75 1.63
Jan 31, 2024 1.69 -0.05 -2.87% 1.74 1.74 1.68
Jan 30, 2024 1.74 -0.01 -0.57% 1.75 1.78 1.73
Jan 29, 2024 1.77 0.02 1.14% 1.75 1.78 1.75
Jan 26, 2024 1.76 0.04 2.33% 1.72 1.81 1.72

DBV Technologies SA Events

Time (UTC) Country Event
Thursday, February 29, 2024

Time (UTC)

10:59

Country

FR

Event

Full Year 2023 Dbv Technologies SA Earnings Release
Full Year 2023 Dbv Technologies SA Earnings Release

Forecast

-

Previous

-
Thursday, April 11, 2024

Time (UTC)

08:00

Country

FR

Event

DBV Technologies SA Annual Shareholders Meeting
DBV Technologies SA Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 4.844 5.708 11.276 14.708 15.9805
Revenue 4.844 5.708 11.276 14.708 15.9805
Cost of Revenue, Total 0.778 0.519 0.272 1.089 1.7325
Gross Profit 4.066 5.189 11.004 13.619 14.248
Total Operating Expense 101.037 103.972 169.224 185.055 198.686
Selling/General/Admin. Expenses, Total 24.527 33.499 43.509 69.211 80.2214
Research & Development 61.069 57.993 81.105 107.92 112.102
Depreciation / Amortization 14.663 12.881 21.344 6.835 4.63025
Operating Income -96.193 -98.264 -157.948 -170.347 -182.706
Interest Income (Expense), Net Non-Operating 0.255 -0.169 -1.727 -1.512 0.156101
Net Income Before Taxes -95.938 -98.433 -159.675 -171.859 -182.551
Net Income After Taxes -96.008 -98.052 -159.665 -172.469 -182.567
Net Income Before Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
Net Income -96.008 -98.052 -159.665 -172.469 -182.567
Income Available to Common Excl. Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
Income Available to Common Incl. Extra. Items -96.008 -98.052 -159.665 -172.469 -182.567
Diluted Net Income -96.008 -98.052 -159.665 -172.469 -182.567
Diluted Weighted Average Shares 77.3841 54.9169 54.0927 37.0073 28.925
Diluted EPS Excluding Extraordinary Items -1.24067 -1.78546 -2.95169 -4.66041 -6.31175
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.24067 -1.79635 -2.67539 -4.66041 -6.31175
Other Operating Expenses, Total
Other, Net -0.001099
Unusual Expense (Income) 0 -0.92 22.994 0
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 4.482 0.77 4.074 4.255 1.453
Revenue 4.482 0.77 4.074 4.255 1.453
Total Operating Expense 50.742 56.702 44.335 41.942 62.03
Selling/General/Admin. Expenses, Total 12.271 15.72 9.414 21.147 12.471
Research & Development 29.913 36.058 25.182 27.597 30.796
Unusual Expense (Income) 0 -0.92
Operating Income -46.26 -55.932 -40.261 -37.687 -60.577
Interest Income (Expense), Net Non-Operating 1.398 -0.572 0.827 -0.101 -0.068
Net Income Before Taxes -44.862 -56.504 -39.434 -37.788 -60.645
Net Income After Taxes -44.875 -56.487 -39.521 -37.811 -60.241
Net Income Before Extra. Items -44.875 -56.487 -39.521 -37.811 -60.241
Net Income -44.875 -56.487 -39.521 -37.811 -60.241
Income Available to Common Excl. Extra. Items -44.875 -56.486 -39.522 -37.812 -60.24
Income Available to Common Incl. Extra. Items -44.875 -56.486 -39.522 -37.812 -60.24
Diluted Net Income -44.875 -56.486 -39.522 -37.812 -60.24
Diluted Weighted Average Shares 94.1501 94.2782 60.4901 54.9411 54.8928
Diluted EPS Excluding Extraordinary Items -0.47663 -0.59914 -0.65336 -0.68823 -1.09741
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.47663 -0.59914 -0.65336 -0.69911 -1.09741
Other Operating Expenses, Total -3.557 -0.001 -6.204 0.001
Total Adjustments to Net Income 0.001 -0.001 -0.001 0.001
Depreciation / Amortization 8.558 8.481 9.74 0.322 18.762
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 223.108 114.516 207.374 204.554 159.913
Cash and Short Term Investments 209.194 77.301 196.352 193.255 134.961
Cash 30.104 31.427 42.341 57.882 84.9055
Cash & Equivalents 179.09 45.874 154.011 135.373 50.0555
Total Receivables, Net 11.235 33.066 7.86 5.415 18.5408
Accounts Receivable - Trade, Net 0 2.23 0
Total Inventory 2.289 1.7215
Prepaid Expenses 2.68 4.149 3.162 3.596 4.68851
Total Assets 246.494 146.323 272.019 271.273 188.804
Property/Plant/Equipment, Total - Net 17.552 24.917 34.669 48.148 22.2267
Property/Plant/Equipment, Total - Gross 32.34 38.716 51.359 59.249 29.9317
Accumulated Depreciation, Total -14.788 -13.799 -16.69 -11.101 -7.70499
Intangibles, Net 0.01 0.022 0.041 0.048 0.03188
Long Term Investments 5.824 6.868 29.935 18.523 6.63207
Total Current Liabilities 29.521 31.398 52.713 53.999 47.8668
Accounts Payable 14.473 11.429 20.338 24.004 31.4037
Accrued Expenses 5.941 6.89 17.241 20.764 7.46534
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 7.213 10.076 11.426 5.545 8.99777
Total Liabilities 51.997 47.294 66.631 78.539 55.474
Total Long Term Debt 1.15 7.147 10.496 21.995 0
Other Liabilities, Total 21.326 8.749 3.422 2.545 7.60715
Total Equity 194.497 99.029 205.388 192.734 133.33
Common Stock 10.72 6.538 6.518 5.645 3.31549
Additional Paid-In Capital 294.881 199.801 996.849 847.274 592.844
Retained Earnings (Accumulated Deficit) -96.594 -101.239 -804.209 -643.239 -462.829
Other Equity, Total -14.51 -6.071 6.23 -16.946
Total Liabilities & Shareholders’ Equity 246.494 146.323 272.019 271.273 188.804
Total Common Shares Outstanding 93.9874 54.9493 54.8787 46.9918 30.1166
Other Current Assets, Total -0.001 -0.001 0.001099
Other Long Term Assets, Total
Current Port. of LT Debt/Capital Leases 1.894 3.003 3.708 3.686
Capital Lease Obligations 1.15 7.147 10.496 21.995
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 195.54 223.108 260.088 114.516
Cash and Short Term Investments 173.961 209.194 247.971 77.301
Cash 24.111 30.104 226.674 31.427
Cash & Equivalents 149.85 179.09 21.297 45.874
Total Receivables, Net 17.084 11.235 11.02 33.066
Total Inventory
Prepaid Expenses 4.494 2.68 1.097 4.149
Other Current Assets, Total 0.001 -0.001
Total Assets 217.478 246.494 284.922 146.323
Property/Plant/Equipment, Total - Net 15.927 17.552 18.597 24.917
Property/Plant/Equipment, Total - Gross 32.34 38.716
Accumulated Depreciation, Total -14.788 -13.799
Intangibles, Net 0.068 0.01 0.014 0.022
Long Term Investments 5.944 5.824 6.223 6.868
Total Current Liabilities 33.373 29.521 30.431 31.398
Accounts Payable 19.094 14.473 16.341 11.429
Accrued Expenses 4.561 5.941 4.535 6.89
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.944 1.894 1.967 3.003
Other Current Liabilities, Total 7.774 7.213 7.588 10.076
Total Liabilities 53.18 51.997 40.501 47.294
Total Long Term Debt 0.187 1.15 1.972 7.147
Capital Lease Obligations 0.187 1.15 1.972 7.147
Other Liabilities, Total 19.62 21.326 8.098 8.749
Total Equity 164.298 194.497 244.421 99.029
Common Stock 10.952 10.72 10.708 6.538
Additional Paid-In Capital 208.974 294.881 295.693 199.801
Retained Earnings (Accumulated Deficit) -44.564 -96.594 -42.574 -101.239
Other Equity, Total -11.064 -14.51 -19.406 -6.071
Total Liabilities & Shareholders’ Equity 217.478 246.494 284.922 146.323
Total Common Shares Outstanding 96.1012 93.9874 54.9493 54.9493
Accounts Receivable - Trade, Net 0
Other Long Term Assets, Total -0.001
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -159.374 -172.469 -175.276 -155.875
Cash From Operating Activities -160.892 -143.885 -144.19 -120.647
Cash From Operating Activities 15.783 6.381 2.98678 3.08809
Non-Cash Items 0.151 18.762 28.444 32.8661
Changes in Working Capital -17.452 3.441 -0.34406 -0.726114
Cash From Investing Activities -2.865 -5.662 -9.11969 -8.26799
Capital Expenditures -2.761 -5.597 -5.01419 -7.96298
Other Investing Cash Flow Items, Total -0.104 -0.065 -4.1055 -0.30501
Cash From Financing Activities 144.837 203.116 137.915 0.301844
Financing Cash Flow Items -1.34 -2.495 -2.05169 -0.580469
Issuance (Retirement) of Stock, Net 149.886 208.938 139.967 0.882313
Foreign Exchange Effects 22.017 -0.886 -0.554084 3.4501
Net Change in Cash 3.097 52.683 -15.9481 -125.163
Cash Interest Paid 1.002 1.135
Issuance (Retirement) of Debt, Net -3.709 -3.327
Dec 2021 Jun 2021 Dec 2020 Jun 2020
Net income/Starting Line -159.374 -91.3383
Cash From Operating Activities -160.892 -83.8345
Cash From Operating Activities 15.783 16.4399
Non-Cash Items 0.151 3.15036
Cash Interest Paid 1.002 0.491815
Changes in Working Capital -17.452 -12.0864
Cash From Investing Activities -2.865 -1.38785
Capital Expenditures -2.761 -1.37202
Other Investing Cash Flow Items, Total -0.104 -0.015831
Cash From Financing Activities 144.837 141.672
Financing Cash Flow Items -1.34 -0.492871
Issuance (Retirement) of Stock, Net 149.886 143.877
Issuance (Retirement) of Debt, Net -3.709 -1.71186
Foreign Exchange Effects 22.017 0.365168
Net Change in Cash 3.097 56.8152
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Baker Bros. Advisors LP Hedge Fund 10.7548 10351838 -1241331 2022-06-13 LOW
Venrock Venture Capital 9.662 9300000 0 2022-12-31 LOW
Bpifrance Participations S.A. Sovereign Wealth Fund 7.1953 6925730 2483130 2022-06-13 LOW
Delaware Braidwell LP Corporation 6.2895 6053892 6053892 2022-05-06
HSBC Global Asset Management (France) S.A. Investment Advisor 0.2935 282544 -1367 2022-12-31 LOW
Bpifrance Investissement Venture Capital 0.2349 226133 33 2022-06-13 LOW
La Française AM Investment Advisor 0.0571 55000 0 2023-06-30 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.0403 38815 0 2023-08-31 LOW
La Francaise Asset Management SAS Investment Advisor 0.039 37574 24 2023-09-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0292 28104 -750 2023-09-30 LOW
de Rosen (Michel) Individual Investor 0.0245 23570 0 2023-02-15 LOW
Robitaille (Sebastien) Individual Investor 0.0214 20599 2287 2023-02-15 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.0205 19758 -62 2022-12-31 LOW
Morris (Timothy E) Individual Investor 0.0125 12000 12000 2023-08-25
Soland (Daniel B) Individual Investor 0.0104 10000 5000 2023-02-15
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.0104 9971 0 2023-08-31 LOW
Mohideen (Pharis MD) Individual Investor 0.0103 9924 4112 2023-02-15 HIGH
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.0004 385 18 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

DBV Technologies Company profile

About DBV Technologies SA

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DBV Technologies SA revenues decreased 49% to $5.7M. Net loss applicable to common stockholders decreased 39% to $98.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and Development decrease of 31% to $70.1M (expense), Restructuring decrease from $23M (expense) to $920K (income).

Industry: Proprietary & Advanced Pharmaceuticals

177-181 avenue Pierre Brossolette
MONTROUGE
ILE-DE-FRANCE 92120
FR

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

18,027.90 Price
+0.270% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.54 Price
-2.220% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

77.40 Price
-1.160% 1D Chg, %
Long position overnight fee 0.0164%
Short position overnight fee -0.0383%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

51,088.60 Price
-1.240% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading